Stock listing
Bioatla, Inc.
Selected listing: BCAB · NASDAQ · USD · US
Bioatla, Inc. (NASDAQ:BCAB), Health Technology. Latest release May 18, 2026: Context Therapeutics Enters into License Agreement Amendment with BioAtla…
- Ticker
- NASDAQ:BCAB
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
About Bioatla, Inc.
Bioatla, Inc. is a public company traded under the ticker BCAB in the American market. Bioatla focuses on developing innovative therapies in the biotechnology sector.
Latest news from Bioatla, Inc.
Context Therapeutics Enters into License Agreement Amendment with BioAtla for CT-202
May 17, 2026
BioAtla Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights
March 30, 2026
BioAtla Announces Share Consolidation
March 30, 2026
BioAtla Announces Formal Process to Evaluate Strategic Options to Monetize Assets
March 2, 2026
BioAtla and GATC Health Announce a $40 Million Special Purpose Vehicle (SPV) Transaction to Advance Ozuriftamab Vedotin (Oz-V) into a Registrational Trial for 2L+ Oropharyngeal Squamous Cell Carcinoma (OPSCC)
December 31, 2025